136 related articles for article (PubMed ID: 36621075)
1. Role of soluble forms of follicular helper T-cell membrane molecules in the pathogenesis of myasthenia gravis.
Akamine H; Uzawa A; Kojima Y; Ozawa Y; Yasuda M; Onishi Y; Kuwabara S
J Neuroimmunol; 2023 Feb; 375():578014. PubMed ID: 36621075
[TBL] [Abstract][Full Text] [Related]
2. Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis.
Yan X; Gu Y; Wang C; Sun S; Wang X; Tian J; Wang M; Ji X; Duan X; Gao H; Fang Q; Dong W; Zhang X; Xue Q
Clin Immunol; 2019 Oct; 207():68-78. PubMed ID: 31374257
[TBL] [Abstract][Full Text] [Related]
3. Intrathymic Tfh/B Cells Interaction Leads to Ectopic GCs Formation and Anti-AChR Antibody Production: Central Role in Triggering MG Occurrence.
Zhang X; Liu S; Chang T; Xu J; Zhang C; Tian F; Sun Y; Song C; Yi W; Lin H; Li Z; Yang K
Mol Neurobiol; 2016 Jan; 53(1):120-131. PubMed ID: 25407929
[TBL] [Abstract][Full Text] [Related]
4. High frequencies of circulating Tfh-Th17 cells in myasthenia gravis patients.
Yang Y; Zhang M; Ye Y; Ma S; Fan L; Li Z
Neurol Sci; 2017 Sep; 38(9):1599-1608. PubMed ID: 28578482
[TBL] [Abstract][Full Text] [Related]
5. Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis.
Berrih S; Morel E; Gaud C; Raimond F; Le Brigand H; Bach JF
Neurology; 1984 Jan; 34(1):66-71. PubMed ID: 6228745
[TBL] [Abstract][Full Text] [Related]
6. CD4
Çebi M; Durmus H; Aysal F; Özkan B; Gül GE; Çakar A; Hocaoglu M; Mercan M; Yentür SP; Tütüncü M; Yayla V; Akan O; Dogan Ö; Parman Y; Saruhan-Direskeneli G
Front Immunol; 2020; 11():809. PubMed ID: 32508812
[TBL] [Abstract][Full Text] [Related]
7. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles.
Xie X; Mu L; Yao X; Li N; Sun B; Li Y; Zhan X; Wang X; Kang X; Wang J; Liu Y; Zhang Y; Wang G; Wang D; Liu X; Kong Q; Li H
Clin Immunol; 2013 Aug; 148(2):162-76. PubMed ID: 23773919
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of T Follicular Helper Cell-Mediated Humoral Immunity Reponses During Development of Experimental Autoimmune Myasthenia Gravis.
Cui YZ; Qu SY; Chang LL; Zhao JR; Mu L; Sun B; Li HL; Zhang TS; Wang GY; Kong QF
Neurosci Bull; 2019 Jun; 35(3):507-518. PubMed ID: 30796753
[TBL] [Abstract][Full Text] [Related]
9. Roles of cytokines and T cells in the pathogenesis of myasthenia gravis.
Uzawa A; Kuwabara S; Suzuki S; Imai T; Murai H; Ozawa Y; Yasuda M; Nagane Y; Utsugisawa K
Clin Exp Immunol; 2021 Mar; 203(3):366-374. PubMed ID: 33184844
[TBL] [Abstract][Full Text] [Related]
10. Effects of Follicular Helper T Cells and Inflammatory Cytokines on Myasthenia Gravis.
Wang L; Zhang Y; Zhu M; Feng J; Han J; Zhu J; Deng H
Curr Mol Med; 2019; 19(10):739-745. PubMed ID: 31453784
[TBL] [Abstract][Full Text] [Related]
11. High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis.
Uzawa A; Akamine H; Kojima Y; Ozawa Y; Yasuda M; Onishi Y; Sawai S; Kawasaki K; Asano H; Ohyama S; Matsushita K; Mori M; Kuwabara S
J Neuroimmunol; 2021 Sep; 358():577634. PubMed ID: 34174586
[TBL] [Abstract][Full Text] [Related]
12. Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis.
Li Y; Guptill JT; Russo MA; Howard JF; Massey JM; Juel VC; Hobson-Webb LD; Emmett D; Chopra M; Raja S; Liu W; Yi JS
J Neuroimmunol; 2020 Aug; 345():577279. PubMed ID: 32497931
[TBL] [Abstract][Full Text] [Related]
13. Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis.
Luo C; Li Y; Liu W; Feng H; Wang H; Huang X; Qiu L; Ouyang J
J Neuroimmunol; 2013 Mar; 256(1-2):55-61. PubMed ID: 23305745
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of circulating Aire and increased Tfh/Tfr cells in myasthenia gravis patients.
Zhao S; Ding J; Wang S; Li C; Guo P; Zhang M; Li Z
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29773681
[TBL] [Abstract][Full Text] [Related]
15. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
[TBL] [Abstract][Full Text] [Related]
16. Effect of tacrolimus on soluble costimulatory molecules in patients with refractory myasthenia gravis.
Wu H; Chen L; Zhou X; Wu Y; Yan Y; Zhu Y; Zhao C; Xue Q
J Neuroimmunol; 2022 Nov; 372():577955. PubMed ID: 36054935
[TBL] [Abstract][Full Text] [Related]
17. [Detection of memory T cells, follicular T cells and relevant cytokines in the peripheral blood of patients with myasthenia gravis during treatment].
Ma L; Wu T; He J; Shen X; Yu F
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Mar; 38(3):257-262. PubMed ID: 35365992
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic administration of fingolimod (FTY720) ameliorated experimental autoimmune myasthenia gravis by reducing the number of dendritic cells, follicular T helper cells and antibody-secreting cells.
Liu Y; Yang CL; Yang B; Du T; Li XL; Zhang P; Ge MR; Lian Y; Li H; Liu YD; Duan RS
Int Immunopharmacol; 2021 Jul; 96():107511. PubMed ID: 33915521
[TBL] [Abstract][Full Text] [Related]
19. Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines.
Hohlfeld R; Kalies I; Kohleisen B; Heininger K; Conti-Tronconi B; Toyka KV
Neurology; 1986 May; 36(5):618-21. PubMed ID: 3486379
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patients.
Li Y; Guptill JT; Russo MA; Massey JM; Juel VC; Hobson-Webb LD; Howard JF; Chopra M; Liu W; Yi JS
Exp Neurol; 2019 Feb; 312():43-50. PubMed ID: 30472069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
